trevitherapeutics.com (TRVI) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Grafik tomonidan tasdiqlangan bozor narxi xarajatlarni boshqarish samaradorligini va dori vositalari sinovlarining shaffofligini baholashga yordam beradi, bunda ko'rsatkich 0.00 darajasida turibdi. Trevi Therapeutics (TRVI) nerv gangliylarini nishonga oluvchi noyob antipruritik va antitussiv agentlarni ishlab chiqishga tayanadi. Bioteknologiyalarga bo'lgan barqaror talab kompaniyani global iqtisodiy tebranishlardan mustaqil qoladigan defensiv aktivga aylantiradi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_TRVI_-_Trevi-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "TRVI - Trevi Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Trevi Therapeutics (TRVI) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Trevi Therapeutics|TRVI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati trevitherapeutics.com|TRVI - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Trevi Therapeutics, Inc.|TRVI - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Trevi Therapeutics|Tezkor likvidlik trevitherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Trevi Therapeutics Inc - TRVI
Investorlar uchun qarz yuklamasini baholash biotexnologiya startaplarini tahlil qilishda juda muhimdir, chunki surunkali yo'teldan davolaydigan dori vositalari uchun klinik sinovlarning yuqori xarajatlari sezilarli kapital xarajatlarni talab qiladi. Uzoq muddatli qarzlarning kapitalga nisbati uzoq muddatli majburiyatlarning aksiyadorlar kapitaliga nisbatan ulushini aks ettiradi, bu esa tartibga soluvchi organlarning tasdiqlashini kutayotgan va biznesni kredit risklaridan himoya qilayotgan Trevi Therapeutics (TRVI) moliyaviy mustaqilligini aniqlash imkonini beradi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati DNLI|HRMY (harmonybiosciences.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PRAX (Praxis Medicines)|Anavex Life Sciences Corp (AVXL) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC: Uzoq muddatli qarzning kapitalga nisbati|ANNX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|NGNE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|Uzoq muddatli kreditlarning kapitalga nisbati VYGR|Uzoq muddatli qarzning kapitalga nisbati NMRA (Neumora Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti SCLX|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alpha Cognition|Cognition Therapeutics (CGTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|inhibikase.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Assertio Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|VTGN: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|acumenpharm.com (ABOS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CRVO: Uzoq muddatli qarzning o'z kapitaliga nisbati|ATHE - Uzoq muddatli qarzning kapitalga nisbati|CLNN (clene.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PEPG: Uzoq muddatli kreditlarning kapitalga nisbati|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|relmada.com (RLMD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|Uzoq muddatli qarzning o'z kapitaliga nisbati gracetx.com GRCE|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc AIFF|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|revivapharma.com - Uzoq muddatli kreditlarning kapitalga nisbati|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeurAxis Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cyclerion Therapeutics|PTIX (protagenic.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|ATXI: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ELYM (Eliem Therapeutics, Inc.)|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning o'z kapitaliga nisbati SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati